Advances in Phenomics Drug Discovery: Combining high content and pathway profiling technologies with multiparametric data analysis tools to discover novel and effective drug mechanisms-of-action.

Time: To be announced
To be announced
Plenary Keynote:
Prof Neil Carragher


Complex heterogenous diseases of unmet need such as glioblastoma, oesophageal cancer and many neurodegenerative diseases continue to confound modern target-based drug discovery strategies. Here I describe how recent advances in multiparametric high content imaging and pathway profiling technologies support a more unbiased and comprehensive survey of pharmacological and therapeutic target classes across heterogenous cancer cell phenotypes. I present data demonstrating how combining these approaches with genetically defined cell model systems and multiparametric data analysis and machine learning tools can enable the identification of mechanism-of-action appropriately tailored to complex disease. I will present case studies describing how these methods can be frontloaded into the earliest stages of drug discovery to accelerate the identification of exciting new drug modes-of-action from phenotypic screens.

To view the video assoicated with this lecture click here

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Web Site Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2022